What nature has kept secret for millions of years, we can now uncover in a single high-throughput experiment.
Our technology harnesses the power of genetics and AI to learn the biophysical parameters governing protein function.
Our team
We are a team of explorers and builders passionate about revolutionising drug discovery.
Boldness
Ingenuity
Determination
Teamwork
Openness
Fairness
Join us
At ALLOX the success of our revolutionary scientific approach is as important to us as our mission to create a healthy, honest and respectful culture, both internally and with our partners.
We believe that — as in other living systems — team robustness and evolvability are a consequence of diversity, and that individuals thrive when they’re empowered with freedom and responsibility.
If you’re excited about the prospect of working with us, get in touch!
News
ALLOX scientists map the first step in Alzheimer’s protein aggregation and discover clues for future therapies
In research published in Science Advances, ALLOX scientists Mireia Seuma, André Faure and Ben Lehner used large-scale genomics and machine learning to study over 140,000 versions of a peptide called Aβ42, which forms harmful plaques in the brain and is known to play a central role in Alzheimer’s disease.
Get in touch
For all enquiries, send us a message here or email us at hello@allox.bio. We look forward to hearing from you!
Investors
This company is capitalized by INNVIERTE, AN INVESTMENT PROGRAM OF CDTI, E.P.E.Grants
- Grant PTQ2023-013021 awarded by MCIU/AEI/10.13039/501100011033
- Grant PTQ2024-013687 awarded by MCIU/AEI/10.13039/501100011033
Parc Científic de Barcelona
C/Baldiri Reixac 4-8 (Torre R),
08028 Barcelona
All our switches